TG Therapeutics, Inc. (TGTX)

41.97 +5.83 (+16.13%) USD  |  NASDAQ  |  May 06, 16:00
41.60 -0.37 (-0.88%) After-Hours: 20:00
More

TG Therapeutics Quarterly Actual Revenue

Quarterly Actual Revenue Chart

View Quarterly Actual Revenue for TGTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Quarterly Actual Revenue Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Quarterly Actual Revenue Range, Past 5 Years

View Quarterly Actual Revenue Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Actual Revenue Benchmarks

View Quarterly Actual Revenue Benchmarks
Start Trial
Precision BioSciences, Inc. Upgrade
Krystal Biotech, Inc. Upgrade
Catalyst Pharmaceuticals, Inc. Upgrade
Geron Corp. Upgrade
Viking Therapeutics, Inc. Upgrade